| Product Code: ETC323126 | Publication Date: Aug 2022 | Updated Date: Aug 2025 | Product Type: Market Research Report | |
| Publisher: 6Wresearch | Author: Ravi Bhandari | No. of Pages: 75 | No. of Figures: 35 | No. of Tables: 20 |
The drug discovery services market in Malaysia is linked to the pharmaceutical and biotechnology sectors. Malaysia has been actively promoting itself as a hub for research and development in the life sciences field. As a result, the market for drug discovery services, including contract research and development, is likely to grow with the increasing emphasis on innovation and drug development.
The drug discovery services market in Malaysia is poised for growth, with increasing investments in pharmaceutical research and development. The country`s well-established healthcare infrastructure and a skilled workforce make it an attractive destination for pharmaceutical companies looking for outsourcing opportunities. The continuous demand for innovative therapies and drug development is expected to fuel the expansion of this market.
The Malaysia drug discovery services market may encounter challenges related to global competition and research funding. To compete on a global scale, market players must invest in cutting-edge technologies and research capabilities. Moreover, the availability of research grants and funding opportunities can impact the growth and sustainability of the market. Collaborating with international partners, securing research grants, and continuously upgrading research infrastructure will be crucial to address these challenges effectively.
The drug discovery services market in Malaysia played a vital role in responding to the pandemic. Local research and development efforts were mobilized to find treatments and vaccines. This has bolstered the reputation of Malaysia as a hub for pharmaceutical research. Going forward, the market is expected to benefit from increased investments in healthcare and biotechnology research, as the importance of preparedness for future health crises is underscored.
The pharmaceutical and biotechnology sectors are driving growth in the Malaysia Drug Discovery Services market. Key players include Charles River Laboratories, Eurofins Scientific, and Evotec SE.
1 Executive Summary |
2 Introduction |
2.1 Key Highlights of the Report |
2.2 Report Description |
2.3 Market Scope & Segmentation |
2.4 Research Methodology |
2.5 Assumptions |
3 Malaysia Drug Discovery Services Market Overview |
3.1 Malaysia Country Macro Economic Indicators |
3.2 Malaysia Drug Discovery Services Market Revenues & Volume, 2021 & 2031F |
3.3 Malaysia Drug Discovery Services Market - Industry Life Cycle |
3.4 Malaysia Drug Discovery Services Market - Porter's Five Forces |
3.5 Malaysia Drug Discovery Services Market Revenues & Volume Share, By Process, 2021 & 2031F |
3.6 Malaysia Drug Discovery Services Market Revenues & Volume Share, By Type, 2021 & 2031F |
3.7 Malaysia Drug Discovery Services Market Revenues & Volume Share, By End user, 2021 & 2031F |
4 Malaysia Drug Discovery Services Market Dynamics |
4.1 Impact Analysis |
4.2 Market Drivers |
4.2.1 Increasing demand for novel drugs and therapies in Malaysia |
4.2.2 Growing investments in research and development activities in the healthcare sector |
4.2.3 Government initiatives to promote drug discovery and innovation |
4.3 Market Restraints |
4.3.1 Stringent regulations and approval processes for new drug development |
4.3.2 High costs associated with drug discovery services |
4.3.3 Limited availability of skilled professionals in the field of drug discovery |
5 Malaysia Drug Discovery Services Market Trends |
6 Malaysia Drug Discovery Services Market, By Types |
6.1 Malaysia Drug Discovery Services Market, By Process |
6.1.1 Overview and Analysis |
6.1.2 Malaysia Drug Discovery Services Market Revenues & Volume, By Process, 2021-2031F |
6.1.3 Malaysia Drug Discovery Services Market Revenues & Volume, By Target Selection, 2021-2031F |
6.1.4 Malaysia Drug Discovery Services Market Revenues & Volume, By Target Validation, 2021-2031F |
6.1.5 Malaysia Drug Discovery Services Market Revenues & Volume, By Hit-to-Lead identification, 2021-2031F |
6.1.6 Malaysia Drug Discovery Services Market Revenues & Volume, By Lead Optimization, 2021-2031F |
6.1.7 Malaysia Drug Discovery Services Market Revenues & Volume, By Candidate Validation, 2021-2031F |
6.2 Malaysia Drug Discovery Services Market, By Type |
6.2.1 Overview and Analysis |
6.2.2 Malaysia Drug Discovery Services Market Revenues & Volume, By Chemistry Services, 2021-2031F |
6.2.3 Malaysia Drug Discovery Services Market Revenues & Volume, By Biology Services, 2021-2031F |
6.3 Malaysia Drug Discovery Services Market, By End user |
6.3.1 Overview and Analysis |
6.3.2 Malaysia Drug Discovery Services Market Revenues & Volume, By Pharmaceutical & Biotechnology companies, 2021-2031F |
6.3.3 Malaysia Drug Discovery Services Market Revenues & Volume, By Academic Institutes, 2021-2031F |
6.3.4 Malaysia Drug Discovery Services Market Revenues & Volume, By Others, 2021-2031F |
7 Malaysia Drug Discovery Services Market Import-Export Trade Statistics |
7.1 Malaysia Drug Discovery Services Market Export to Major Countries |
7.2 Malaysia Drug Discovery Services Market Imports from Major Countries |
8 Malaysia Drug Discovery Services Market Key Performance Indicators |
8.1 Number of collaborations between pharmaceutical companies and research institutions in Malaysia |
8.2 Percentage increase in research funding allocated to drug discovery projects |
8.3 Number of patents filed for new drug discoveries in Malaysia |
8.4 Percentage growth in the number of clinical trials conducted in the country |
8.5 Rate of adoption of advanced technologies in drug discovery services in Malaysia |
9 Malaysia Drug Discovery Services Market - Opportunity Assessment |
9.1 Malaysia Drug Discovery Services Market Opportunity Assessment, By Process, 2021 & 2031F |
9.2 Malaysia Drug Discovery Services Market Opportunity Assessment, By Type, 2021 & 2031F |
9.3 Malaysia Drug Discovery Services Market Opportunity Assessment, By End user, 2021 & 2031F |
10 Malaysia Drug Discovery Services Market - Competitive Landscape |
10.1 Malaysia Drug Discovery Services Market Revenue Share, By Companies, 2024 |
10.2 Malaysia Drug Discovery Services Market Competitive Benchmarking, By Operating and Technical Parameters |
11 Company Profiles |
12 Recommendations |
13 Disclaimer |
Export potential enables firms to identify high-growth global markets with greater confidence by combining advanced trade intelligence with a structured quantitative methodology. The framework analyzes emerging demand trends and country-level import patterns while integrating macroeconomic and trade datasets such as GDP and population forecasts, bilateral import–export flows, tariff structures, elasticity differentials between developed and developing economies, geographic distance, and import demand projections. Using weighted trade values from 2020–2024 as the base period to project country-to-country export potential for 2030, these inputs are operationalized through calculated drivers such as gravity model parameters, tariff impact factors, and projected GDP per-capita growth. Through an analysis of hidden potentials, demand hotspots, and market conditions that are most favorable to success, this method enables firms to focus on target countries, maximize returns, and global expansion with data, backed by accuracy.
By factoring in the projected importer demand gap that is currently unmet and could be potential opportunity, it identifies the potential for the Exporter (Country) among 190 countries, against the general trade analysis, which identifies the biggest importer or exporter.
To discover high-growth global markets and optimize your business strategy:
Click Here